WASHINGTON, March 18, 2008 — King & Spalding, a leading international law firm, will organize and host two medical device summits in Chicago and Boston for clients and friends of the firm. Both conferences will focus on how to navigate the regulatory challenges associated with marketing medical devices. The two events will take place April 17-18 at the Westin Chicago North Shore in Wheeling, Ill., and June 26-27 at the Hyatt Harborside at Logan International Airport in Boston, Mass.
Former staff members of the U.S. Food and Drug Administration, U.S. Department of Justice and the U.S. Congress will provide insights on current FDA and the Centers for Medicare and Medicaid Services requirements and policies, as well as the most effective go-to-market strategies, including:
- Premarket challenges and strategies
- Clinical trials
- Reimbursement
- Medical device reporting
- Inspections and recalls
- FDA enforcement activities
- Combination products
- Advertising and promotion
- Device provisions in new FDA legislation
- Product liability
- Government investigations
Industry guest speakers are Irene Jakimcius, senior counsel of regulatory affairs at Baxter Healthcare, and Tracy Palmer Berns, associate general counsel for regulatory affairs at Covidien.
King & Spalding speakers include the following members of the firm’s FDA/healthcare practice: Edward M. Basile, senior partner; John Bentivoglio, partner; Jennifer Bragg, partner; Mark Brown, partner; Laurie Clarke, partner; Kirk Dobbins, counsel; Pamela Furman, partner, Anne Kelly, consultant; Laura Loeb, partner; Beverly Lorell, M.D., senior medical and policy advisor; Elaine Tseng, counsel; and Lynette Zentgraft, consultant.
CLE credit will be applied in Illinois and Massachusetts for certain sessions, and a Certificate of Attendance will be provided for attorneys licensed in other states to use to apply for CLE credit.
King & Spalding's FDA/healthcare practice represents pharmaceutical, medical device, biotechnology and other healthcare technology companies, as well as food manufacturers, in a wide range of regulatory, compliance, policy, and litigation matters. More than 30 lawyers and non-lawyer professionals in the firm’s Washington, D.C. office provide sophisticated counseling and advice to more than 150 drug and device manufacturers and others in the healthcare technology sector, including nine of the 25 largest pharmaceutical manufacturers and 18 of the 25 largest device manufacturers.
For more information about the conference, please click here.
About King & Spalding
King & Spalding is an international law firm with more than 800 lawyers in Atlanta, Charlotte, Dubai, Frankfurt, Houston, London, New York, Riyadh (affiliated office), San Francisco, Silicon Valley and Washington, D.C. The firm represents half of the Fortune 100 and in a Corporate Counsel survey in September 2007 was among the top firms representing Fortune 250 companies. For additional information, visit www.kslaw.com.
